Photodynamic Therapy (PDT)
PDT combines the application of a photosensitizing topical medication, aminolevulinic acid HCl (ALA), with a particular wave length of light (BLU-light) activation. This treatment is FDA approved for the treatment of a type of precancerous Lesions called Actinic keratoses (AKs). AKs commonly develop on sun exposed areas, such as the face and scalp. Because AKs commonly progress into non-melanoma types of skin cancers, PDT has become a first line treatment to avoid deforming invasive surgeries. PDT-ALA is also prescribed for treating sebaceous gland enlargement as commonly occurs in Rosacea and moderate to severe acne.
Our experienced staff will apply the medication, following a thorough microdermabrasion of the treatment area, to enhance ALA penetration. Patients will need to spend a prescribed period of time in our waiting room allowing the targeted abnormal epidermal cells to metabolize the ALA into photosensitive molecules. Activation with the BLU-light safely destroys the target cells. Post-treatment requires 48 hours of complete sunblock/solar avoidance, so schedule your PDT treatment with plans to remain indoors afterward.